CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia

Kiran Musunuru, MD, PhD, MPH

Kiran Musunuru, MD presents his talk on CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia at the 2018 Scientific Sessions in Las Vegas, Nevada.

Rating: 
0
No votes yet

This page was last updated: Jul 09, 2018